Temporal and spatial increase of reactive nitrogen species in the kainate model of temporal lobe epilepsy

Neurobiology of Disease

Volumn 64, Issue , 2014, Pages 8-15

  Ryan, Kristen ^a   Liang, Li Ping ^a   Rivard, Christopher ^a   Patel, Manisha ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Mitochondria; Nitrogen species; Oxidative stress; Posttranslational modification; Reactive oxygen species; Temporal lobe epilepsy

Indexed keywords

3 NITROTYROSINE; CELL MARKER; COENZYME A; GLUTATHIONE; KAINIC ACID; NITRIC OXIDE; REACTIVE NITROGEN SPECIES;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPTOGENESIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MALE; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TEMPORAL LOBE EPILEPSY;

MITOCHONDRIA; NITROGEN SPECIES; OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATION; REACTIVE OXYGEN SPECIES; TEMPORAL LOBE EPILEPSY;

ANIMALS; ASTROCYTES; COENZYME A; EPILEPSY, TEMPORAL LOBE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HIPPOCAMPUS; KAINIC ACID; MALE; MITOCHONDRIA; NEURONS; NITRIC OXIDE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE NITROGEN SPECIES; SEIZURES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TYROSINE;

EID: 84891752718     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.12.006     Document Type: Article

References (58)

1. Aguiar C.C., et al. Oxidative stress and epilepsy: literature review. Oxid. Med. Cell. Longev. 2012, 2012:795259.
2. Alderton W.K., et al. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
3. Aquilano K., et al. Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells. J. Cell Sci. 2011, 124:1043-1054.
4. Aquilano K., et al. Glutathione is a crucial guardian of protein integrity in the brain upon nitric oxide imbalance. Commun. Integr. Biol. 2011, 4:477-479.
5. Beal M.F., et al. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 1990, 55:1327-1339.
6. Bharath S., Andersen J.K. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. Antioxid. Redox Signal. 2005, 7:900-910.
7. Brown G.C., Neher J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 2010, 41:242-247.
8. Chavko M., et al. Relationship between protein nitration and oxidation and development of hyperoxic seizures. Nitric Oxide 2003, 9:18-23.
9. Chinta S.J., Andersen J.K. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic Biol Med. 2006, 41:1442-1448.
10. Chinta S.J., Andersen J.K. Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. Free Radic. Res. 2011, 45:53-58.
11. Chuang Y.C., et al. Upregulation of nitric oxide synthase II contributes to apoptotic cell death in the hippocampal CA3 subfield via a cytochrome c/caspase-3 signaling cascade following induction of experimental temporal lobe status epilepticus in the rat. Neuropharmacology 2007, 52:1263-1273.
12. Coeroli L., et al. Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J. Neurochem. 1998, 70:2516-2525.
13. Dahm C.C., et al. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 2006, 281:10056-10065.
14. Dalle-Donne I., et al. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9:169-176.
15. Dalle-Donne I., et al. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52:601-623.
16. Delgado-Escueta A.V., et al. New waves of research in the epilepsies: crossing into the third millennium. Adv. Neurol. 1999, 79:3-58.
17. Giasson B.I., et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
18. Giustarini D., et al. S-glutathionylation: from redox regulation of protein functions to human diseases. J. Cell. Mol. Med. 2004, 8:201-212.
19. Gluck M.R., et al. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res. 2000, 39:63-71.
20. Hall E.D., et al. Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J. Neurotrauma 2004, 21:9-20.
21. Hess D.T., et al. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6:150-166.
22. Huang C.J., et al. Microdialysis for measurement of hepatic and systemic nitric oxide biosynthesis in septic rats. Acta Anaesthesiol. Scand. 2005, 49:28-34.
23. Hurd T.R., et al. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage. J. Biol. Chem. 2008, 283:24801-24815.
24. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 1998, 356:1-11.
25. Ischiropoulos H., Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005, 208:299-303.
26. Jaffrey S.R., Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001, 2001:pl1.
27. Jarrett S.G., et al. Mitochondrial DNA damage and impaired base excision repair during epileptogenesis. Neurobiol. Dis. 2008, 30:130-138.
28. Jha N., et al. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 2000, 275:26096-26101.
29. Keeney P.M., et al. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 2006, 26:5256-5264.
30. Kunz W.S., et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol. 2000, 48:766-773.
31. Liang L.P., Patel M. Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med. 2006, 40:316-322.
32. Liang L.P., et al. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 2000, 101:563-570.
33. Liang L.P., et al. Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin. Neurobiol. Dis. 2012, 45:1068-1076.
34. Maggio R., et al. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Res. 1995, 679:184-187.
35. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
36. Mollace V., et al. Evidence that l-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport 1991, 2:269-272.
37. Moncada S., Bolanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 2006, 97:1676-1689.
38. Mulsch A., et al. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport 1994, 5:2325-2328.
39. Nakamura T., et al. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp. Neurol. 2012, 238:12-21.
40. Orth M., Schapira A.H. Mitochondria and degenerative disorders. Am. J. Med. Genet. 2001, 106:27-36.
41. Osonoe K., et al. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 1994, 663:338-340.
42. Patel M., et al. Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage. J. Neurochem. 2005, 92:123-131.
43. Patel M., et al. Seizure-induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension. J. Neurochem. 2008, 104:264-270.
44. Pennathur S., et al. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o, o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 1999, 274:34621-34628.
45. Petruzzella V., et al. Dysfunction of mitochondrial respiratory chain complex I in neurological disorders: genetics and pathogenetic mechanisms. Adv. Exp. Med. Biol. 2012, 942:371-384.
46. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
47. Reed D.J., Savage M.K. Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status. Biochim. Biophys. Acta 1995, 1271:43-50.
48. Ryan K., et al. Post-translational oxidative modification and inactivation of mitochondrial complex I in epileptogenesis. J. Neurosci. 2012, 32:11250-11258.
49. Sawa T., et al. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J. Biol. Chem. 2000, 275:32467-32474.
50. Sharma A.K., et al. Temporal profile of clinical signs and histopathologic changes in an F-344 rat model of kainic acid-induced mesial temporal lobe epilepsy. Toxicol. Pathol. 2008, 36:932-943.
51. Souza J.M., et al. Protein tyrosine nitration-functional alteration or just a biomarker?. Free Radic. Biol. Med. 2008, 45:357-366.
52. Sultana R., et al. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 2006, 8:2021-2037.
53. Szabo C., et al. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 2007, 6:662-680.
54. Valko M., et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
55. Waldbaum S., Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 2010, 88:23-45.
56. Waldbaum S., et al. Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpine-induced epileptogenesis. J. Neurochem. 2010, 115:1172-1182.
57. Wang Q., et al. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res. 1994, 658:192-198.
58. Wong Y.L., et al. Mitochondrial thiol status in the liver is altered by exposure to hyperoxia. Toxicol. Lett. 2001, 123:179-193.